Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples